179 related articles for article (PubMed ID: 23328270)
1. The effects of ethanol on the pharmacokinetics, pharmacodynamics, safety, and tolerability of ezogabine (retigabine).
Crean CS; Tompson DJ
Clin Ther; 2013 Jan; 35(1):87-93. PubMed ID: 23328270
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
Tompson DJ; Crean CS; Reeve R; Berry NS
Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
[TBL] [Abstract][Full Text] [Related]
5. The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent.
Crean CS; Tompson DJ; Buraglio M
Int J Clin Pharmacol Ther; 2013 Nov; 51(11):847-53. PubMed ID: 24040852
[TBL] [Abstract][Full Text] [Related]
6. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
Porter RJ; Burdette DE; Gil-Nagel A; Hall ST; White R; Shaikh S; DeRossett SE
Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
Biton V; Gil-Nagel A; Brodie MJ; Derossett SE; Nohria V
Epilepsy Res; 2013 Nov; 107(1-2):138-45. PubMed ID: 24094693
[TBL] [Abstract][Full Text] [Related]
8. The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Brickel N; Gandhi P; VanLandingham K; Hammond J; DeRossett S
Epilepsia; 2012 Apr; 53(4):606-12. PubMed ID: 22428574
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
Lim KS; Lotay N; White R; Kwan P
Epilepsy Behav; 2016 Aug; 61():224-230. PubMed ID: 27376872
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
[TBL] [Abstract][Full Text] [Related]
12. Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.
Yamada M; Welty TE
Ann Pharmacother; 2012 Oct; 46(10):1358-67. PubMed ID: 22991134
[TBL] [Abstract][Full Text] [Related]
13. Effect of hemodialysis on pharmacokinetics of ezogabine/retigabine and its N-acetyl metabolite in patients with end stage renal disease.
Tompson DJ; Buraglio M; Bullman J; Crean CS; Rayner K
Curr Clin Pharmacol; 2014; 9(4):319-25. PubMed ID: 25387761
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
[TBL] [Abstract][Full Text] [Related]
15. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
Chen C; Upward J; Arumugham T; Stier B; Davy M
Clin Ther; 2015 Feb; 37(2):349-57. PubMed ID: 25467190
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
Gunthorpe MJ; Large CH; Sankar R
Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability.
Brodie MJ; French JA; McDonald SA; Lee WJ; Adams B; Scott A; Nohria V; DeRossett S
Epilepsy Res; 2014 Jul; 108(5):989-94. PubMed ID: 24726452
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participants.
Setnik B; Sokolowska M; Johnson F; Oldenhof J; Romach M
Hum Psychopharmacol; 2014 May; 29(3):251-65. PubMed ID: 24911576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
